Evaluation of Risk Factors for Antibiotic Resistance in Patients with Nosocomial Infections Caused byPseudomonas aeruginosa
Open Access
- 30 August 2016
- journal article
- research article
- Published by Hindawi Limited in Canadian Journal of Infectious Diseases and Medical Microbiology
- Vol. 2016, 1-9
- https://doi.org/10.1155/2016/1321487
Abstract
Background.Pseudomonas aeruginosa(P. aeruginosa) is resistant to various antibiotics and can cause serious nosocomial infections with high morbidity and mortality. In this clinical study, we investigated the risk factors in patients who were diagnosed withP. aeruginosa-related nosocomial infection.Methods. A retrospective case control study including patients withP. aeruginosa-related nosocomial infection. Patients who were resistant to any of the six antibiotics (imipenem, meropenem, piperacillin-tazobactam, ciprofloxacin, amikacin, and ceftazidime) constituted the study group.Results. One hundred and twenty isolates were isolated. Various risk factors were detected for each antibiotic in the univariate analysis. In the multivariate analysis, previous cefazolin use was found as an independent risk factor for the development of imipenem resistance (OR = 3.33; CI 95% [1.11–10.0];= 0.03), whereas previous cerebrovascular attack (OR = 3.57; CI 95% [1.31–9.76];= 0.01) and previous meropenem use (OR = 4.13; CI 95% [1.21–14.07];= 0.02) were independent factors for the development of meropenem resistance. For the development of resistance to ciprofloxacin, hospitalization in the neurology intensive care unit (OR = 4.24; CI 95% [1.5–11.98];= 0.006) and mechanical ventilator application (OR = 11.7; CI 95% [2.24–61.45];= 0.004) were independent risk factors.Conclusion. The meticulous application of contact measures can decrease the rate of nosocomial infections.
Keywords
This publication has 39 references indexed in Scilit:
- Surveillance and Correlation of Antimicrobial Usage and Resistance of Pseudomonas aeruginosa: A Hospital Population-Based StudyPLOS ONE, 2013
- Risk Factors for Mortality in Patients with Pseudomonas aeruginosa Bacteremia: Clinical Impact of Antimicrobial Resistance on OutcomeMicrobial Drug Resistance, 2011
- Infection control practice in countries with limited resourcesAnnals of Clinical Microbiology and Antimicrobials, 2011
- Previous ciprofloxacin exposure is associated with resistance to β-lactam antibiotics in subsequent Pseudomonas aeruginosa bacteremic isolatesAmerican Journal of Infection Control, 2009
- Relationship between Various Definitions of Prior Antibiotic Exposure and Piperacillin-Tazobactam Resistance among Patients with Respiratory Tract Infections Caused by Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 2008
- CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care settingAmerican Journal of Infection Control, 2008
- Nosocomial acquisition of Pseudomonas aeruginosa resistant to both ciprofloxacin and imipenem: a risk factor and laboratory analysisEuropean Journal of Clinical Microbiology & Infectious Diseases, 2008
- Imipenem-Resistant Pseudomonas aeruginosa : Risk Factors for Nosocomial InfectionsJournal of Korean Medical Science, 2008
- The Epidemiology, Pathogenesis and Treatment of Pseudomonas aeruginosa InfectionsDrugs, 2007
- Nosocomial Infections With Ceftazidime-Resistant Pseudomonas aeruginosa: Risk Factors and OutcomeInfection Control & Hospital Epidemiology, 1999